Scopolamine Hydrobromide Injection (2016-01-22)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| (L) 290638E01 | - Recalling Firm
- Hospira Healthcare Corporation, a Pfizer Company
- 2600 Alfred-Nobel Blvd. Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation, a Pfizer Company
- 2600 Alfred-Nobel Blvd. Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
| Scopolamine Hydrobromide Injection | Sterile solution for injection | DIN 00541877 | 0.6 mg/ml |
Affected products
Scopolamine Hydrobromide Injection
Downward trend in potency during shelf life testing. Risk of potency falling below specifications before expiry date is reached
Wholesalers and hospitals across Canada